Alcohol
Volume 27, Issue 2 , Pages 135-141 , June 2002

Acute effect of ethanol on anxiety and 5-HT in the prefrontal cortex of rats

Received 8 August 2001 ,Revised 3 January 2002 ,Accepted 11 March 2002.

References 

  1. Allan CA. Alcohol problems and anxiety disorders—a critical review. Alcohol Alcohol. 1995;30:145–151
  2. Amen DG. Regional cerebral blood flow in alcohol-induced violence (a case study). J Psychoactive Drugs. 1999;31:389–393
  3. Ciccocioppo R, Angeletti S, Colombo G, Gessa G, Massi M. Autoradiographic analysis of 5-HT2A binding sites in the brain of Sardinian alcohol-preferring and nonpreferring rats. Eur J Pharmacol. 1999;373:13–19
  4. Deckel AW, Shoemaker WJ, Arky L. Effects of 5,7-dihydroxytryptamine lesions of the prefrontal cortex on consumption of sucrose–ethanol solutions (relationship to prefrontal monoamines). Alcohol Clin Exp Res. 1997;21:631–636
  5. Dekeyne A, Brocco M, Adhumeau A, Gobert A, Millan MJ. The selective serotonin (5-HT)1A receptor ligand, S15535, displays anxiolytic-like effects in the social interaction and Vogel models and suppresses dialysate levels of 5-HT in the dorsal hippocampus of freely-moving rats. A comparison with other anxiolytic agents. Psychopharmacology (Berl). 2000;152:55–66
  6. Ferreira VM, Takahashi RN, Morato GS. Dexamethasone reverses the ethanol-induced anxiolytic effect in rats. Pharmacol Biochem Behav. 2000;66:585–590
  7. Garbutt JC, West SL, Carey TS, Lohr KN, Crews FT. Pharmacological treatment of alcohol dependence (a review of the evidence). JAMA. 1999;281:1318–1325
  8. Gonzalez LE, Rujano M, Tucci S, Paredes D, Silva E, Alba G, et al. Medial prefrontal transection enhances social interaction. I (behavioral studies). Brain Res. 2000;887:7–15
  9. Graeff FG, Guimaraes FS, De Andrade TG, Deakin JFW. Role of 5-HT in stress, anxiety, and depression. Pharmacol Biochem Behav. 1996;54:129–141
  10. Grant, K. A. (1995). Animal models of the alcohol addiction process. In H. R. Kranzler (Ed.), The Pharmacology of Alcohol Abuse (Handbook Exp Pharmacol, vol. 114) (pp. 185–229). Berlin: Springer.
  11. Griebel G. 5-Hydroxytryptamine-interacting drugs in animal models of anxiety disorders (more than 30 years of research). Pharmacol Ther. 1995;65:319–395
  12. Hall FS, Huang S, Fong GW, Pert A, Linnoila M. Effects of isolation-rearing on locomotion, anxiety and responses to ethanol in Fawn Hooded and Wistar rats. Psychopharmacology (Berl). 1998;139:203–209
  13. Hashimoto S, Inoue T, Koyama T. Effects of conditioned fear stress on serotonin neurotransmission and freezing behavior in rats. Eur J Pharmacol. 1999;378:23–30
  14. Higgins, G. A., Lê, A. D., & Sellers, E. M. (1995). 5-HT mediation of alcohol self-administration, tolerance and dependence: pre-clinical studies. In H. R. Kranzler (Ed.), The Pharmacology of Alcohol Abuse (Handbook Exp Pharmacol, vol. 114) (pp. 139–168). Berlin: Springer.
  15. Hwang BH, Zhang JK, Ehlers CL, Lumeng L, Li T-K. Innate differences of neuropeptide Y (NPY) in hypothalamic nuclei and central nucleus of the amygdala between selectively bred rats with high and low alcohol preference. Alcohol Clin Exp Res. 1999;23:1023–1030
  16. Inoue T, Tsuchiya K, Koyama T. Serotonergic activation reduces defensive freezing in the conditioned fear paradigm. Pharmacol Biochem Behav. 1996;53:825–831
  17. Kushner MG, Abrams K, Thuras P, Thuras P, Hanson KL. Individual differences predictive of drinking to manage anxiety among non-problem drinkers with panic disorder. Alcohol Clin Exp Res. 2000;24:448–458
  18. LaBuda CJ, Fuchs PN. Aspirin attenuates the anxiolytic actions of ethanol. Alcohol. 2000;21:287–290
  19. Lacroix L, Spinelli S, Heidbreder CA, Feldon J. Differential role of the medial and lateral prefrontal cortices in fear and anxiety. Behav Neurosci. 2000;114:1119–1130
  20. Lovinger DM. 5-HT3 receptors and the neural actions of alcohols (an increasingly exciting topic). Neurochem Int. 1999;35:125–130
  21. Lucki I. The spectrum of behaviors influenced by serotonin. Biol Psychiatry. 1998;44:151–162
  22. Maki Y. A behavioral and neurochemical study on the mechanism of the anxiolytic effect of monoamine oxidase inhibitors. Hokkaido Igaku Zasshi. 2001;76:133–142
  23. McBride WJ, Chernet E, Rabold JA, Lumeng L, Li T-K. Serotonin-2 receptors in the CNS of alcohol-preferring and -nonpreferring rats. Pharmacol Biochem Behav. 1993;46:631–636
  24. Morato GS, Ferreira VM, Ferrara P, Farges RC. Effects of central and systemic injections of peripheral benzodiazepine receptor ligands on the anxiolytic actions of ethanol in rats. Addict Biol. 2001;6:129–136
  25. Newlin DB, Thomson JB. Alcohol challenge with sons of alcoholics (a critical review and analysis). Psychol Bull. 1990;108:383–402
  26. Overstreet DH, Rezvani AH, Pucilowski O, Janowsky DS. 5-HT receptors (implications for the neuropharmacology of alcohol and alcoholism). Alcohol Alcohol Suppl. 1994;2:205–210
  27. Paxinos G, Watson C. The Rat Brain in Stereotaxic Coordinates. San Diego: Academic Press; 1986;
  28. Prunell M, Escorihuela RM, Fernandez-Teruel A, Nunez JF, Tobena A. Differential interactions between ethanol and Ro 15-4513 on two anxiety tests in rats. Pharmacol Biochem Behav. 1994;47:147–151
  29. Ramos A, Berton O, Mormede P, Chaouloff F. A multiple-test study of anxiety-related behaviours in six inbred rat strains. Behav Brain Res. 1997;85:57–69
  30. Rex A, Marsden CA, Fink H. Effect of diazepam on cortical 5-HT release and behaviour in the guinea-pig on exposure to the elevated plus maze. Psychopharmacology (Berl). 1993;110:490–496
  31. Rex A, Sondern U, Voigt JP, Franck S, Fink H. Strain differences in fear-motivated behavior of rats. Pharmacol Biochem Behav. 1996;54:107–111
  32. Rex A, Voigt JP, Fink H. Behavioral and neurochemical differences between Fischer 344 and Harlan–Wistar rats raised identically. Behav Genet. 1999;29:187–192
  33. Rex A, Voigt JP, Fink H. Anxiety but not general unspecific activation increases 5-HT release in the rat hippocampus in vivo. In:  O'Connor WT,  Lowry JP,  O'Connor JJ,  O'Neill RD editor. Monitoring Molecules in Neuroscience–2001. Dublin: University College–Dublin; 2001;p. 168–169
  34. Roberts AC, Wallis JD. Inhibitory control and affective processing in the prefrontal cortex (neuropsychological studies in the common marmoset). Cereb Cortex. 2000;10:252–262
  35. Rueter LE, Fornal CA, Jacobs BL. A critical review of 5-HT brain microdialysis and behavior. Rev Neurosci. 1997;8:117–137
  36. Selim M, Bradberry CW. Effect of ethanol on extracellular 5-HT and glutamate in the nucleus accumbens and prefrontal cortex (comparison between the Lewis and Fischer 344 rat strains). Brain Res. 1996;716:157–164
  37. Sellers EM, Higgins GA, Sobell MB. 5-HT and alcohol abuse. Trends Pharmacol Sci. 1992;13:69–75
  38. Simpson JR, Drevets WC, Snyder AZ, Gusnard DA, Raichle ME. Emotion-induced changes in human medial prefrontal cortex (II. During anticipatory anxiety). Proc Natl Acad Sci U S A. 2001;98:688–693
  39. van Raaij MT, Dobbe CJ, Elvers B, Timmerman A, Schenk E, Oortigiesen M, et al. Hormonal status and the neuroendocrine response to a novel heterotypic stressor involving subchronic noise exposure. Neuroendocrinology. 1997;65:200–209
  40. Weiss F, Parsons LH, Schulteis G, Hyytia P, Lorang MT, Bloom FE, et al. Ethanol self-administration restores withdrawal-associated deficiencies in accumbal dopamine and 5-hydroxytryptamine release in dependent rats. J Neurosci. 1996;16:3474–3485
  41. Wilson J, Watson WP, Little HJ. CCK(B) antagonists protect against anxiety-related behaviour produced by ethanol withdrawal, measured using the elevated plus maze. Psychopharmacology (Berl). 1998;137:120–131
  42. Yan Q-S. Extracellular dopamine and serotonin after ethanol monitored with 5-minute microdialysis. Alcohol. 1999;19:1–7
  43. Yoshimoto K, Yoshida T, Sorimachi Y, Hirano A, Takeuchi Y, Ueda S, et al. Effects of age and ethanol on dopamine and serotonin release in the rat nucleus accumbens. Physiol Behav. 1998;64:347–351
  44. Yoshioka M, Matsumoto M, Togashi H, Saito H. Effects of conditioned fear stress on 5-HT release in the rat prefrontal cortex. Pharmacol Biochem Behav. 1995;51:515–519
  45. Zohar J, Westenberg HG. Anxiety disorders (a review of tricyclic antidepressants and selective serotonin reuptake inhibitors). Acta Psychiatr Scand Suppl. 2000;403:39–49

☆ Editor: S. Borg

PII: S0741-8329(02)00219-7

Alcohol
Volume 27, Issue 2 , Pages 135-141 , June 2002

Article Tools

* Image Usage & Resolution